Journal article
Pain and the relationship with mood and anxiety disorders and psychological symptoms
LJ Williams, JA Pasco, FN Jacka, S Dodd, M Berk
Journal of Psychosomatic Research | Published : 2012
Abstract
Objective: The objective of this study was to investigate the association between pain and mood and anxiety disorders, as well as psychological symptoms, in a population-based sample of women. Methods: This study examined the data collected from 1067 women aged 20-93. years (median 51. years) participating in the Geelong Osteoporosis Study. Mood and anxiety disorders were diagnosed using a clinical interview (SCID-I/NP) and psychological symptomatology was assessed using the General Health Questionnaire. Pain was determined using a Visual Analogue Scale (0-100. mm) and deemed present if score. ≥. 40. mm. Results: Current mood disorders were associated with an increased likelihood of overall ..
View full abstractGrants
Funding Acknowledgements
Lana Williams has received grant/research support from Eli Lilly, Pfizer, The University of Melbourne, Deakin University and the NHMRC.Julie Pasco has received speaker fees from Amgen, Eli Lilly and Sanofi-Aventis and funding from the Geelong Region Medical Research Foundation, Barwon Health, Perpetual Trustees, the Dairy Research and Development Corporation, The University of Melbourne, the Ronald Geoffrey Arnott Foundation, ANZ Charitable Trust, the American Society for Bone and Mineral Research, Amgen (Europe) GmBH and the NHMRC.Felice Jacka has received grant/research support from the Brain and Behaviour Research Institute, NHMRC, Australian Rotary Health, Geelong Medical Research Foundation and The University of Melbourne, and has been a paid speaker for Sanofi-Synthelabo and Eli Lilly.Seetal Dodd has received grant/research support from the Stanley Medical Research Institute, NHMRC, Beyond Blue, ARHRF, Simons Foundation, Geelong Medical Research Foundation, Eli Lilly, Glaxo SmithKline, Organon, Mayne Pharma, Servier and been a paid speaker for Eli Lilly.Michael Berk has received grant/research support from the NIH, Simons Foundation, CRC for Mental Health, Stanley Medical Research Institute, MBF, NHMRC, Beyond Blue, Geelong Medical Research Foundation, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Organon, Novartis, Mayne Pharma, Servier and Astra Zeneca. He has been a paid consultant for Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck and Pfizer and a paid speaker for Astra Zeneca, Bristol Myers Squibb, Eli Lilly, Glaxo SmithKline, Janssen Cilag, Lundbeck, Organon, Pfizer, Sanofi Synthelabo, Solvay and Wyeth.The study was funded by the National Health and Medical Research Council of Australia and supported by an unrestricted educational grant from Eli Lilly.